NANO-DIAMINO-TETRAC Trademark

Trademark Overview


On Monday, June 29, 2015, a trademark application was filed for NANO-DIAMINO-TETRAC with the United States Patent and Trademark Office. The USPTO has given the NANO-DIAMINO-TETRAC trademark a serial number of 86676911. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 18, 2019. This trademark is owned by NanoPharmaceuticals LLC. The NANO-DIAMINO-TETRAC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents and preparations affecting macular degeneration, solid tumors, hematologic malignancies, ocular disorders, angiogenesis, arthritis, dermatology, digestive organs, metabolism, peripheral nervous system, sensory organs, central nervous system, hormonal disorders, diabetes, eye diseases and conditions, heart disorders, joint disease, cancer and the prevention and treatment of cancer, hyperthyroidism, Alzheimer's disease, respiratory diseases, chemotherapy and radioactive in vivo diagnostic or therapeutic use; radioactive pharmaceutical preparations for use in in vivo diagnostic; appetite suppressants; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based injectable, eye drop or oral delivery tablets or capsules for the continuous release of a wide variety of therapeutic agents; pharmaceutical skin lotion, cream, ointment, and skin patch
nano-diamino-tetrac

General Information


Serial Number86676911
Word MarkNANO-DIAMINO-TETRAC
Filing DateMonday, June 29, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 18, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 17, 2015

Trademark Statements


Goods and ServicesPharmaceutical agents and preparations affecting macular degeneration, solid tumors, hematologic malignancies, ocular disorders, angiogenesis, arthritis, dermatology, digestive organs, metabolism, peripheral nervous system, sensory organs, central nervous system, hormonal disorders, diabetes, eye diseases and conditions, heart disorders, joint disease, cancer and the prevention and treatment of cancer, hyperthyroidism, Alzheimer's disease, respiratory diseases, chemotherapy and radioactive in vivo diagnostic or therapeutic use; radioactive pharmaceutical preparations for use in in vivo diagnostic; appetite suppressants; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based injectable, eye drop or oral delivery tablets or capsules for the continuous release of a wide variety of therapeutic agents; pharmaceutical skin lotion, cream, ointment, and skin patch

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 6, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNanoPharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRensselaer, NY 12144

Party NameNanoPharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRensselaer, NY 12144

Trademark Events


Event DateEvent Description
Tuesday, February 19, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 18, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 16, 2018EXTENSION 5 GRANTED
Monday, July 9, 2018EXTENSION 5 FILED
Monday, July 16, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 9, 2018TEAS EXTENSION RECEIVED
Thursday, December 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 19, 2017EXTENSION 4 GRANTED
Tuesday, December 19, 2017EXTENSION 4 FILED
Tuesday, December 19, 2017TEAS EXTENSION RECEIVED
Saturday, July 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 6, 2017EXTENSION 3 GRANTED
Thursday, July 6, 2017EXTENSION 3 FILED
Thursday, July 6, 2017TEAS EXTENSION RECEIVED
Thursday, January 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 3, 2017EXTENSION 2 GRANTED
Tuesday, January 3, 2017EXTENSION 2 FILED
Tuesday, January 3, 2017TEAS EXTENSION RECEIVED
Friday, July 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 6, 2016EXTENSION 1 GRANTED
Wednesday, July 6, 2016EXTENSION 1 FILED
Wednesday, July 6, 2016TEAS EXTENSION RECEIVED
Tuesday, January 12, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 17, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 28, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 8, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 7, 2015ASSIGNED TO EXAMINER
Monday, July 6, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 2, 2015NEW APPLICATION ENTERED IN TRAM